A detailed history of Gamble Jones Investment Counsel transactions in Danaher Corp stock. As of the latest transaction made, Gamble Jones Investment Counsel holds 3,370 shares of DHR stock, worth $800,981. This represents 0.07% of its overall portfolio holdings.

Number of Shares
3,370
Previous 3,370 -0.0%
Holding current value
$800,981
Previous $870,000 2.76%
% of portfolio
0.07%
Previous 0.07%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 05, 2022

SELL
$237.11 - $299.66 $94,844 - $119,864
-400 Reduced 10.61%
3,370 $854,000
Q4 2021

Feb 09, 2022

SELL
$292.08 - $329.01 $23,366 - $26,320
-80 Reduced 2.08%
3,770 $1.24 Million
Q3 2021

Nov 09, 2021

SELL
$272.21 - $332.43 $21,776 - $26,594
-80 Reduced 2.04%
3,850 $1.17 Million
Q1 2021

May 10, 2021

SELL
$212.38 - $245.9 $31,857 - $36,885
-150 Reduced 3.68%
3,930 $885,000
Q4 2020

Feb 10, 2021

SELL
$212.5 - $245.46 $4,250 - $4,909
-20 Reduced 0.49%
4,080 $906,000
Q3 2020

Nov 10, 2020

SELL
$177.16 - $215.33 $2,657 - $3,229
-15 Reduced 0.36%
4,100 $883,000
Q3 2019

Nov 04, 2019

SELL
$135.4 - $146.47 $190,914 - $206,522
-1,410 Reduced 25.52%
4,115 $594,000
Q2 2019

Aug 20, 2019

SELL
$124.88 - $143.73 $66,186 - $76,176
-530 Reduced 8.75%
5,525 $790,000
Q1 2019

May 02, 2019

SELL
$97.62 - $132.29 $48,810 - $66,145
-500 Reduced 7.63%
6,055 $799,000
Q4 2018

Feb 04, 2019

SELL
$94.85 - $109.54 $7,113 - $8,215
-75 Reduced 1.13%
6,555 $676,000
Q3 2018

Nov 06, 2018

SELL
$98.13 - $108.9 $29,439 - $32,670
-300 Reduced 4.33%
6,630 $720,000
Q1 2018

May 10, 2018

SELL
$92.16 - $103.8 $11,520 - $12,975
-125 Reduced 1.77%
6,930 $679,000
Q4 2017

Feb 06, 2018

BUY
$85.26 - $94.62 $6,394 - $7,096
75 Added 1.07%
7,055 $655,000
Q3 2017

Nov 14, 2017

BUY
$79.29 - $88.45 $553,444 - $617,381
6,980
6,980 $599,000

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $173B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Gamble Jones Investment Counsel Portfolio

Follow Gamble Jones Investment Counsel and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gamble Jones Investment Counsel, based on Form 13F filings with the SEC.

News

Stay updated on Gamble Jones Investment Counsel with notifications on news.